signaling pathway kinase modulators (Prosalix)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug Namesignaling pathway kinase modulators (Prosalix)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProtein kinases inhibitors

TargetsProtein kinases

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesProsalix GmbH

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesProsalix GmbH

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A